Avaleht › Atoopiline dermatiit (ekseem) › Georgia
Atoopiline dermatiit (ekseem) kliinilised uuringud osariigis Georgia
9 uuringut haiguse Atoopiline dermatiit (ekseem) jaoks otsivad osalejaid osariigis Georgia.
Linnad osariigis Georgia
Ametlik uuringutekst (inglise keeles)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Skin Care Physicians of Georgia - Macon- Site Number : 8400034, Macon
VärbamineVaatlusuuring
Vanused 12 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Atlanta
- Novartis Investigative Site, Macon
VärbamineFaas 2
Vanused 18–100 · Kõik sood · Uuendatud 28. sept 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Atlanta
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 25. sept 2026 · NCT07298395A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Douglasville
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. sept 2026 · NCT07003425A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
- Hamilton Research, LLC, Alpharetta
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT07223697A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Georgia Skin & Cancer Center, Savannah
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 28. aug 2026 · NCT07599813A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Emory University School Of Medicine - Atlanta /ID# 268832, Atlanta
- Aeroallergy Research Laboratory /ID# 267247, Savannah
VärbamineFaas 3
Vanused 2–11 · Kõik sood · Uuendatud 6. aug 2026 · NCT06461897A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Macon
VärbamineFaas 3
6 Months – 11 Years · Kõik sood · Uuendatud 7. juuli 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Centricity Research Columbus Dermatology /ID# 266529, Columbus
- Cleaver Medical Group Dermatology /ID# 263788, Dawsonville
VärbamineFaas 3
Vanused 18–63 · Kõik sood · Uuendatud 6. juuli 2026 · NCT06389136Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.